Hacker Newsnew | past | comments | ask | show | jobs | submitlogin

> The purpose of PAS was to create a low manganese environment in the body,

Do you have a source for this?

I searched, but this recent paper on the mechanism of action for para-Aminosalicylic Acid (PAS) doesn't even mention manganese. It says it targets Dihydrofolate Reductase pathways: https://pmc.ncbi.nlm.nih.gov/articles/PMC5395024/

Searching for manganese and TB leads me to papers showing that manganese is an essential cofactor for Isoniazid's anti-TB action: https://pubmed.ncbi.nlm.nih.gov/31319159/ but nothing about inducing low manganese states would be helpful or intentional.

So I don't think I'm dead wrong at all. Unless you have some sources, I don't think inducing manganese deficiency is actually the mechanism of action for PAS.

> we have a lot of data showing how well people do with low manganese for a period of 1-2 years. (That was the time that this treatment required.) It wasn't pleasant (in particular it came with nausea), but it was definitely survivable.

Again, do you have any source for this? Preferably a source that indicates what manganese levels were reduced to during treatment?

The side effects are likely due to the 3 drugs in combination which have their own side effects, not low manganese (if it occurred).

EDIT: This commenter was making the same claim down thread and admitted they couldn't find a source for their claim: https://news.ycombinator.com/item?id=45932379 It seems like they're making assumptions and presenting it as scientific fact.



"cofactor is a non-protein chemical compound or metallic ion that is required for an enzyme to function as a catalyst."




Guidelines | FAQ | Lists | API | Security | Legal | Apply to YC | Contact

Search: